LAKESHORE BIOPHARMA CO LTD (LSB)
KYG9845F1090 - Common Stock
| 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2021-12-31) | 2021 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -433.46M | -145.48M | -550.00K | 0.00 | |||
| Depreciation Amortization | 42.19M | 36.69M | 31.15M | 27.91M | |||
| Income Taxes - Deferred | -21.73M | 1.13M | 4.94M | 17.45M | |||
| Change In Working Capital | -45.79M | -92.75M | 440.00K | -186.68M | |||
| Interest Paid | 30.13M | 27.29M | 2.40M | 8.12M | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 34.11M | |||
| Other non cash items | 163.57M | 17.93M | -510.00K | 0.00 | |||
| OPERATING CASH FLOW | -295.23M | -182.47M | -610.00K | 0.00 | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -44.25M | -57.05M | -298.93M | -104.88M | |||
| Other Investing Activity | 0.00 | 68.00K | -200.00M | 644.84K | |||
| INVESTING CASH FLOW | -44.25M | -56.98M | -200.00M | -104.24M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | -78.93M | 100.88M | -360.00K | 8.26M | |||
| Stock Issued/Repurchased | 284.20M | N/A | 202.00M | 731.00M | |||
| Other Financing Activity | 0.00 | 216.57M | -140.00K | N/A | |||
| FINANCING CASH FLOW | 205.26M | 317.45M | 201.50M | 739.26M | |||
| Exchange Rate Effect | 10.40M | 21.30M | -11.48M | -2.67K | |||
| CHANGE IN CASH | -123.82M | 99.30M | 890.00K | 0.00 | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -295.23M | -182.47M | -610.00K | 0.00 | |||
| Capital Expenditure | -44.25M | -57.05M | -298.93M | -104.88M | |||
| FREE CASH FLOW | -339.48M | -239.52M | -610.00K | 0.00 | |||
All data in CNY